Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer

OBJECTIVE: The outcome of the androgen-deprivation therapy (ADT) may be affected by metabolic diseases such as diabetes mellitus (DM) and dyslipidemia and/or by their treatments. We aimed to evaluate the prognostic impact of these disorders and corresponding medications in Japanese men treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirata, Yu, Shiota, Masaki, Kobayashi, Takeshi, Kashiwagi, Eiji, Takeuchi, Ario, Inokuchi, Junichi, Tatsugami, Katsunori, Eto, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962726/
https://www.ncbi.nlm.nih.gov/pubmed/31970142
http://dx.doi.org/10.1016/j.prnil.2019.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962726/
https://www.ncbi.nlm.nih.gov/pubmed/31970142
http://dx.doi.org/10.1016/j.prnil.2019.10.003

Ejemplares similares